Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PRMT5 | O14744 | 14/20 | 0.41 |
| ▸ | WDR77 | Q9BQA1 | 9/20 | 0.41 |
| ▸ | DNMT1 | P26358 | 1/20 | 0.35 |
| ▸ | DNMT3B | Q9UBC3 | 1/20 | 0.35 |
| ▸ | ADK | P55263 | 1/20 | 0.34 |
| ▸ | METTL3 | Q86U44 | 5/20 | 0.33 |
| ▸ | RIPK2 | O43353 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31526280 | 0.90 | DNMT1 (0.37) | PRMT5WDR77DNMT1DNMT3BADK | |
| SCHEMBL31526310 | 0.90 | PRMT5 (0.42) | PRMT5WDR77DNMT1DNMT3BADK | |
| SCHEMBL31526301 | 0.89 | DNMT1 (0.38) | PRMT5WDR77DNMT1DNMT3BADK | |
| SCHEMBL31526285 | 0.88 | ADK (0.37) | PRMT5ADKRIPK2 | |
| SCHEMBL31526407 | 0.88 | DNMT1 (0.40) | PRMT5WDR77DNMT1DNMT3BADK | |
| SCHEMBL31526288 | 0.87 | DNMT1 (0.37) | PRMT5WDR77DNMT1DNMT3BADK | |
| SCHEMBL31526120 | 0.86 | DNMT1 (0.49) | PRMT5WDR77DNMT1DNMT3BADK | |
| SCHEMBL31526122 | 0.85 | DNMT1 (0.37) | PRMT5WDR77DNMT1DNMT3BADK | |
| SCHEMBL31526142 | 0.84 | RIPK2 (0.39) | ADKRIPK2 | |
| SCHEMBL31526309 | 0.83 | DNMT1 (0.37) | PRMT5WDR77DNMT1DNMT3BADK |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025098545-A1 | NUCLEOSIDE DERIVATIVES AS ANTIVIRAL AGENTS AGAINST CORONAVIRUSES | USTAV ORGANICKE CHEMIE A BIOCHEMIE AV CR, V. V. I. (CZ) | 2025-05-15 | — | — | WO | disclosed |
| EP-4553080-A1 | NUCLEOSIDE DERIVATIVES AS ANTIVIRAL AGENTS AGAINST CORONAVIRUSES | Ustav Organicke Chemie a Biochemie AV CR, v.v.i. (CZ) | 2025-05-14 | — | — | EP | disclosed |